The medicines regulator has approved the drug EURneffy for emergency use in a move welcomed by allergy campaigners.

The first needle-free emergency treatment for anaphylaxis – in the form of a nasal spray – will now be available in the UK.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for EURneffy, an adrenaline ...

Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...

Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.

The first needle-free emergency treatment for anaphylaxis - in the form of a nasal spray - will now be available in the UK.

EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) ...

Many mistake allergic rhinitis for a cold, but testing like skin prick tests and targeted treatments such as immunotherapy ...